Edition:
United Kingdom

Brainstorm Cell Therapeutics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

3.05USD
12 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.05
Open
$3.11
Day's High
$3.12
Day's Low
$2.98
Volume
25,444
Avg. Vol
10,026
52-wk High
$5.34
52-wk Low
$2.88

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.153
Jun '18 0.00 -0.158
Mar '18 0.00 -0.121
FY 2017 Dec '17 0.00 0.015
Sep '17 0.00 -0.128
Jun '17 0.00 -0.056
Mar '17 0.00 -0.096
FY 2016 Dec '16 0.00 -0.033
Sep '16 0.00 -0.086
Jun '16 0.00 -0.052
Mar '16 0.00 -0.096
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 0.75 1.50 0.00 --
Quarter Ending Mar-19 1 1.50 1.50 1.50 --
Year Ending Dec-18 2 0.75 1.50 0.00 0.00
Year Ending Dec-19 2 3.00 6.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 2 -0.10 -0.04 -0.16 -0.31
Quarter Ending Mar-19 1 -0.02 -0.02 -0.02 -0.28
Year Ending Dec-18 2 -0.47 -0.35 -0.60 -1.18
Year Ending Dec-19 2 -0.38 -0.10 -0.66 -1.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 81.01 29.57
P/E High - Last 5 Yrs. -- 267.91 46.44
P/E Low - Last 5 Yrs. -- 85.11 24.51
Beta 1.52 0.74 0.88
Price to Sales (TTM) -- 232.78 15.43
Price to Book (MRQ) 6.45 16.33 4.06
Price to Tangible Book (MRQ) 6.45 20.88 13.80
Price to Cash Flow (TTM) -- 48.95 21.23
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.40 1.64
Dividend Yield - 5 Year Avg -- 0.22 1.45
Dividend 5 Year Growth Rate -- 3.72 -5.78
Payout Ratio(TTM) -- 7.81 41.88

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 148.87 7.10
Sales (TTM) vs TTM 1 Yr. Ago -- 63.88 5.63
Sales - 5 Yr. Growth Rate -- 22.16 7.39
EPS (MRQ) vs Qtr. 1 Yr. Ago -19.68 46.11 36.31
EPS (TTM) vs TTM 1 Yr. Ago -33.66 -- --
EPS - 5 Yr. Growth Rate -- 20.32 7.73
Capital Spending - 5 Yr. Growth Rate 14.87 34.35 8.00

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.36 2.55
Current Ratio (MRQ) 3.33 6.59 3.51
LT Debt to Equity (MRQ) 0.00 18.51 11.13
Total Debt to Equity (MRQ) 0.00 23.97 14.84
Interest Coverage (TTM) -- -205.37 40.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 32.29 54.38
Gross Margin - 5 Yr. Avg. -- 47.38 52.96
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -162.73 15.85
Operating Margin (TTM) -- -1,819.18 -16.28
Operating Margin - 5 Yr. Avg. -- -175.96 11.08
Pre-Tax Margin (TTM) -- -1,749.43 -14.67
Pre-Tax Margin - 5 Yr. Avg. -- -178.84 11.39
Net Profit Margin (TTM) -- -1,744.55 -18.01
Net Profit Margin - 5 Yr. Avg. -- -178.80 7.65
Effective Tax Rate (TTM) -- 14.32 21.32
Effective Tax Rate - 5 Yr. Avg. -- 18.97 24.45

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 24,520,427 722,980,797
Net Income/Employee (TTM) -345,375 -3,918,019 83,628,555
Receivable Turnover (TTM) -- 8.33 5.19
Inventory Turnover (TTM) -- 2.80 4.12
Asset Turnover (TTM) 0.00 0.47 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -66.04 -0.91 10.15
Return on Assets - 5 Yr. Avg. -64.15 2.43 10.82
Return on Investment (TTM) -109.26 -0.53 12.77
Return on Investment - 5 Yr. Avg. -83.18 2.24 13.88
Return on Equity (TTM) -109.26 -3.22 14.47
Return on Equity - 5 Yr. Avg. -84.87 -1.62 15.19
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 1.21 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Brainstorm Cell Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 12.10%
# of Holders: 43
Total Shares Held: 2,506,437
3 Mo. Net Change: -4,426
# New Positions: 2
# Closed Positions: 4
# Increased Positions: 5
# Reduced Positions: 6
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.